Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01177683 |
| Title | Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Sherif Farag, MB, BS |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Indiana University Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
| IU Health Central Indiana Cancer Centers | Indianapolis | Indiana | 46219 | United States | Details | |
| Community Regional Cancer Center | Indianapolis | Indiana | 46256 | United States | Details | |
| IU Health Arnett Cancer Center | Lafayette | Indiana | 47904 | United States | Details | |
| Metro Health Cancer Care | Wyoming | Michigan | 49519 | United States | Details | |
| University of Rochester Medical Center | Rochester | New York | 14642 | United States | Details | |
| University Hospitals Seidman Cancer Center | Cleveland | Ohio | 44106 | United States | Details |